| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| JS-014 | Exenokine-21; JS-014; AWT-008 | Phase 1 Clinical | Anwita Biosciences Inc | Solid tumours; Neoplasms; Lymphoma | Details |
| Latikafusp | AMG-256 | Phase 1 Clinical | Amgen Inc | Solid tumours | Details |

BettinastraBe 30, 60325 Frankfurt am Main



